한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

however, the global supply of monkeypox vaccine is currently limited, and further efforts and collaboration are needed. who recommends behavioral changes as preventive measures, and avoiding contact with infected people is essential. at the same time, due to insufficient vaccine supply, many countries and regions can only seek help through medical institutions and try to limit contact. in the face of this special situation, all parties need to work together to meet the challenges of the epidemic.

in addition to prevention and control measures, international cooperation is also crucial. governments, health organizations and pharmaceutical companies should strengthen communication, share data and resources, and jointly respond to the monkeypox epidemic. for example, haicheng pharmaceutical, asia pacific pharmaceutical, cape bio, tengjing life and pril bio are actively contributing to the prevention and control work.

as the monkeypox epidemic spreads, a deeper understanding of its transmission mechanism, symptoms and risk factors is needed. the public's lack of awareness of the monkeypox epidemic may also affect the prevention and control of the epidemic. in order to meet these challenges, governments and medical institutions need to strengthen publicity and develop more detailed prevention measures. at the same time, data collection and analysis should be strengthened, and more in-depth research on the monkeypox epidemic should be conducted to provide more powerful guidance for responding to the epidemic.

**globally, joint action is the only option. **only through international cooperation can the monkeypox epidemic be effectively controlled and the lives of people around the world be protected.